The company's uninspiring revenue growth rate, coupled with ...
The company's uninspiring revenue growth rate, coupled with lack of profits, still saw a 20% annual increase in share price. A 4.6% total return for shareholders over the last year nearly aligns with the market's -4.8% return.
Recent 8.5% Pullback Isn't Enough to Hurt Long-term GuangYuYuan Chinese Herbal Medicine (SHSE:600771) Shareholders, They're Still up 74% Over 3 Years
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment